pmed.1003485.g001.tif (634.89 kB)
CVD risk profile by country for men and women aged 30–64 years.The numbers in the green section of the stacked bars represent the median 10-year CVD risk along with the interquartile range for the country.
figure
posted on 2021-03-04, 21:20 authored by David Peiris, Arpita Ghosh, Jennifer Manne-Goehler, Lindsay M. Jaacks, Michaela Theilmann, Maja E. Marcus, Zhaxybay Zhumadilov, Lindiwe Tsabedze, Adil Supiyev, Bahendeka K. Silver, Abla M. Sibai, Bolormaa Norov, Mary T. Mayige, Joao S. Martins, Nuno Lunet, Demetre Labadarios, Jutta M. A. Jorgensen, Corine Houehanou, David Guwatudde, Mongal S. Gurung, Albertino Damasceno, Krishna K. Aryal, Glennis Andall-Brereton, Kokou Agoudavi, Briar McKenzie, Jacqui Webster, Rifat Atun, Till Bärnighausen, Sebastian Vollmer, Justine I. Davies, Pascal GeldsetzerAll estimates are age-standardised using the Global Burden of Disease project’s 2017 global population. *The age range included in the sample varied in these 5 countries: India—30–49 years for women and 30–54 years for men; Ecuador—30–59 years for both men and women; Namibia—35–64 years for both men and women; Lesotho—30–49 years for women and 30–59 years for men; Albania—30–49 years for both men and women. CVD, cardiovascular disease; EEM, Europe and the Eastern Mediterranean; StVG, Saint Vincent and the Grenadines.
History
Usage metrics
Categories
Keywords
CVD riskSTEPSWorld Health OrganizationMedian 10- year CVD riskCVD Risk Chart Working Group non-la...self-reported blood pressureEssential Noncommunicable Disease I...socio-demographic characteristicsCardiovascular disease risk profileBP medication45 study countriesrepresentative household surveys45 LMICsCVD risk statusrepresentative individual-level sur...sample age range10- year CVD riskcountry survey methodslaboratory-based CVD risk equationsIQRguideline-indicated BP medicationBP medication indicationsBP medication use
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC